Clinical Trial Update: Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1b/Phase 2 clinical trial evaluating food-based modulation of biomarkers in tissues from individuals at high risk for oral cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hypopharyngeal Cancer
• Laryngeal Cancer
• Nasopharyngeal Cancer
• Oral Cancer
• Oral Cavity Squamous Cell Carcinoma
• Oropharyngeal Cancer
• Paranasal Sinus and Nasal Cavity Cancer
• Tongue Cancer

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: COMPLETED